# Vireo Growth Inc.

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/fi/companies/Vireo Growth Inc.).

## Overview

Vireo Growth Inc. is a U.S.-based cannabis company that cultivates, manufactures, distributes, and sells cannabis products through wholesale channels and owned or operated dispensaries. Its operations are concentrated in state-licensed markets across Maryland, Minnesota, Missouri, Nevada, New York, and Utah.

## Products & services

• Cultivation of cannabis flower and biomass
• Manufacturing of cannabis products
• Wholesale distribution to third-party dispensaries
• Retail sales through owned/operated dispensaries
• Medical and adult-use cannabis products

- **Cultivation** (25%) — Growing cannabis plants and producing raw material for downstream processing and sale.
- **Manufacturing** (20%) — Processing cultivated cannabis into finished products for wholesale and retail channels.
- **Wholesale** (25%) — Selling cannabis products to third-party dispensaries and other licensed buyers.
- **Retail Dispensaries** (30%) — Operating Green Goods and other dispensaries that sell directly to approved patients and adult-use customers.

- Cultivation of cannabis flower and biomass
- Manufacturing of cannabis products
- Wholesale distribution to third-party dispensaries
- Retail sales through owned/operated dispensaries
- Medical and adult-use cannabis products

## Customers

Vireo sells to two main customer groups: licensed third-party dispensaries in wholesale markets and end consumers who purchase through its owned or operated retail stores. Its retail customers include approved medical patients and adult-use consumers in the states where it operates, while wholesale customers buy finished cannabis products for resale.

- **Medical patients** (primary) — Buy cannabis products through dispensaries for approved medical use and consistent product access.
- **Adult-use consumers** (primary) — Purchase cannabis products at retail stores in states where adult-use sales are permitted.
- **Wholesale dispensaries** (secondary) — Buy cannabis products for resale in licensed third-party retail outlets.

- Approved medical patients buying cannabis products for therapeutic use
- Adult-use consumers purchasing through company-owned dispensaries
- Third-party dispensaries sourcing wholesale cannabis products
- Licensed market participants needing state-compliant supply
- Customers seeking branded products and local retail access

## Geography

Vireo operates in six U.S. states: Maryland, Minnesota, Missouri, Nevada, New York, and Utah. Its retail footprint spans 36 dispensaries across these markets, while wholesale sales are concentrated in Maryland, Minnesota, and New York. The state-by-state structure matters because cannabis licensing, retail access, and market maturity vary materially by jurisdiction.

- **Maryland** (0%) — State operating market; no revenue share disclosed in the excerpts.
- **Minnesota** (0%) — State operating market; no revenue share disclosed in the excerpts.
- **Missouri** (0%) — State operating market; no revenue share disclosed in the excerpts.
- **Nevada** (0%) — State operating market; no revenue share disclosed in the excerpts.
- **New York** (0%) — State operating market; no revenue share disclosed in the excerpts.
- **Utah** (0%) — State operating market; no revenue share disclosed in the excerpts.

- Operations span Maryland, Minnesota, Missouri, Nevada, New York, and Utah
- Retail sales come from 36 dispensaries across the six-state footprint
- Wholesale sales are concentrated in Maryland, Minnesota, and New York
- State licensing shapes where the company can cultivate, process, and sell
- Limited-license markets can support local supply discipline and access

## Strategy

Vireo’s stated focus is on building a customer-centric cannabis platform across cultivation, manufacturing, wholesale, and retail. The company emphasizes operating in limited-license markets, using its dispensary network and state-licensed subsidiaries to control access to customers and product flow.

- **Deepen vertical integration** (medium-term) — Owning cultivation, manufacturing, wholesale, and retail improves control over supply and customer access.
- **Strengthen presence in limited-license markets** (medium-term) — Restricted licensing can support durable local market positions and distribution access.
- **Increase customer-centric retail execution** (short-term) — Direct retail relationships can improve brand visibility and capture more end-market demand.

- Expand and optimize a vertically integrated cannabis platform
- Focus on limited-license state markets with controlled access
- Use retail dispensaries to strengthen direct customer relationships
- Maintain wholesale channels to monetize production beyond retail
- Allocate capital toward assets that can generate long-term value

## Risks

Vireo faces regulatory and licensing risk because cannabis operations depend on state approvals, local compliance, and market-specific rules. It also faces execution risk from operating across multiple states and business lines, plus industry-wide risks such as price pressure, product quality control, and changes in cannabis laws.

- **Regulatory approval risk for transactions and asset sales** [high] — Cannabis assets often require government and regulatory consent before closing.
- **Transaction completion risk** [high] — The company may not obtain approvals or satisfy conditions precedent, preventing expected benefits.
- **Multi-state operating complexity** [medium] — Different state rules, retail footprints, and wholesale channels increase operational complexity.
- **Cannabis market competition and pricing pressure** [medium] — Wholesale and retail cannabis markets can be fragmented and price competitive.

- State regulatory approvals can delay or block transactions and expansion
- Cannabis licensing and compliance requirements vary by jurisdiction
- Multi-state operations increase execution and integration complexity
- Wholesale and retail demand can fluctuate by market and product mix
- Cannabis industry pricing and competition can pressure margins

## Accounting

Key accounting issues include revenue recognition across wholesale and retail cannabis sales, which may differ by channel and timing of delivery. Investors should also watch estimates tied to inventory adjustments, stock-based compensation, debt extinguishment, and fair value changes in warrants, all of which can materially affect reported results.

- **Revenue recognition by channel** — Affects quarterly comparability and reported revenue timing
- **Inventory valuation and adjustments** — Can change cost of sales and margin presentation
- **Stock-based compensation** — Affects operating expenses and adjusted earnings reconciliation
- **Debt extinguishment and interest expense** — Can materially affect other expense and net income
- **Warrant fair value accounting** — Introduces earnings volatility unrelated to core cannabis operations

- Retail and wholesale revenue timing can differ by channel and state
- Inventory adjustments can affect cost of sales and gross profit
- Stock-based compensation is material and affects operating results
- Debt extinguishment and interest expense can swing other expense
- Fair value changes in warrants can create non-cash earnings volatility

---

*Last updated: 2026-04-29T05:08:14.926478+00:00*